WELLINGTON MANAGEMENT GROUP LLP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$223,000
-81.0%
3,614
-73.7%
0.00%
Q3 2018$1,174,000
-53.7%
13,745
-37.2%
0.00%
-100.0%
Q2 2018$2,536,000
+104.5%
21,875
+42.6%
0.00%
Q1 2018$1,240,000
+88.4%
15,336
+36.7%
0.00%
Q4 2017$658,000
-36.9%
11,221
-66.9%
0.00%
Q1 2017$1,043,000
-27.4%
33,872
-21.0%
0.00%
Q4 2016$1,437,000
+42.3%
42,878
+13.0%
0.00%
Q3 2016$1,010,000
-56.8%
37,957
-64.2%
0.00%
-100.0%
Q2 2016$2,336,000
-4.2%
105,942
+27.6%
0.00%0.0%
Q1 2016$2,438,000
+137.2%
83,016
+166.6%
0.00%
Q4 2015$1,028,000
-1.2%
31,136
-8.4%
0.00%
Q1 2015$1,040,000
+152.4%
33,973
+319.4%
0.00%
Q4 2014$412,000
-94.5%
8,100
-97.5%
0.00%
-100.0%
Q3 2013$7,432,000
+23.9%
324,291
-4.3%
0.00%0.0%
Q2 2013$5,999,000338,7910.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders